Condition
Ischemic Cerebral Infarction
Total Trials
5
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
80%
4 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (1)
P 3 (3)
P 4 (1)
Trial Status
Not Yet Recruiting2
Recruiting1
Completed1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07749287Phase 3CompletedPrimary
Use of Hydrogen Sulphide Donor (N-acetyl Cysteine) in Cases With Acute Ischemic Stroke
NCT07556887Not ApplicableRecruiting
Clinical Impact of Using IMPROVE to Select Patients for Carotid Revascularisation
NCT07242599Phase 3Not Yet RecruitingPrimary
Ongericimab Injection Reducing Recurrence of Ischemic Stroke
NCT07121088Phase 4Not Yet RecruitingPrimary
Traditional Chinese Medicine Intervention for Ischemic Cerebrovascular Disease and Diabetes Mellitus: An Efficacy Comparative Study
NCT04205578Phase 3Unknown
NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events
Showing all 5 trials